Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Receivables (2016 - 2025)

Prestige Consumer Healthcare has reported Change in Receivables over the past 16 years, most recently at -$495000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$495000.0 for Q4 2025, down 107.84% from a year ago — trailing twelve months through Dec 2025 was $27.3 million (up 385.15% YoY), and the annual figure for FY2025 was $16.3 million, up 158.26%.
  • Change in Receivables for Q4 2025 was -$495000.0 at Prestige Consumer Healthcare, down from $29.9 million in the prior quarter.
  • Over the last five years, Change in Receivables for PBH hit a ceiling of $29.9 million in Q3 2025 and a floor of -$27.3 million in Q2 2025.
  • Median Change in Receivables over the past 5 years was $2.0 million (2022), compared with a mean of $3.7 million.
  • Biggest five-year swings in Change in Receivables: tumbled 824.98% in 2024 and later surged 3726.04% in 2025.
  • Prestige Consumer Healthcare's Change in Receivables stood at -$12.5 million in 2021, then surged by 170.56% to $8.8 million in 2022, then grew by 29.88% to $11.4 million in 2023, then plummeted by 44.74% to $6.3 million in 2024, then crashed by 107.84% to -$495000.0 in 2025.
  • The last three reported values for Change in Receivables were -$495000.0 (Q4 2025), $29.9 million (Q3 2025), and -$27.3 million (Q2 2025) per Business Quant data.